CN Stock MarketDetailed Quotes

300878 Zhejiang Wecome Pharmaceutical

Watchlist
  • 18.60
  • -0.46-2.41%
Trading Nov 18 13:40 CST
2.69BMarket Cap-80869P/E (TTM)

Zhejiang Wecome Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-14.16%370.85M
-6.15%296.99M
2.15%199.95M
-2.41%519.62M
-8.93%432M
7.04%316.44M
6.50%195.74M
-15.88%532.44M
-5.40%474.35M
-10.91%295.62M
Operating revenue
-14.16%370.85M
-6.15%296.99M
2.15%199.95M
-2.41%519.62M
-8.93%432M
7.04%316.44M
6.50%195.74M
-15.88%532.44M
-5.40%474.35M
-10.91%295.62M
Other operating revenue
----
9.42%2.46M
----
--5.07M
----
12.56%2.25M
----
----
----
412.42%2M
Total operating cost
15.38%414.72M
8.07%285.14M
5.33%173.89M
13.37%560.07M
-5.05%359.42M
7.03%263.85M
1.34%165.1M
-8.16%494.02M
-3.94%378.54M
-5.44%246.51M
Operating cost
7.90%195.11M
2.29%143.89M
-3.83%102.13M
17.66%257.76M
4.36%180.82M
21.95%140.67M
20.12%106.2M
7.19%219.08M
29.03%173.26M
21.38%115.35M
Operating tax surcharges
599.98%9.05M
719.62%5.58M
2,717.77%4.72M
47.68%2.81M
22.67%1.29M
-30.08%680.79K
-79.22%167.57K
-60.27%1.91M
-67.27%1.05M
-51.49%973.65K
Operating expense
32.10%163.24M
26.26%105.65M
30.78%52.34M
7.85%208.19M
-13.44%123.57M
-10.95%83.68M
-29.87%40.02M
-28.50%193.03M
-37.08%142.75M
-35.33%93.97M
Administration expense
15.76%33.17M
16.08%21.78M
25.20%10.77M
9.60%40.94M
3.38%28.65M
6.10%18.77M
-1.88%8.61M
50.93%37.36M
55.69%27.72M
51.42%17.69M
Financial expense
-62.31%1.97M
-53.62%1.65M
-24.60%956.97K
127.40%7.56M
-8.11%5.22M
423.19%3.57M
2,018.35%1.27M
209.69%3.33M
253.39%5.69M
126.32%682.06K
-Interest expense (Financial expense)
-31.32%4.2M
-21.14%3.18M
-6.59%1.24M
74.69%9.45M
-14.31%6.12M
293.39%4.04M
199.35%1.33M
150.52%5.41M
9,754.63%7.14M
1,316.61%1.03M
-Interest Income (Financial expense)
-65.34%-2.31M
-65.70%-1.58M
-43.98%-616.54K
11.97%-1.98M
11.73%-1.4M
19.68%-951.67K
19.84%-428.22K
57.46%-2.25M
62.71%-1.59M
59.30%-1.18M
Research and development
-38.69%12.18M
-60.08%6.58M
-66.40%2.97M
8.84%42.8M
-29.22%19.87M
-7.66%16.48M
13.23%8.84M
6.23%39.32M
80.05%28.07M
92.54%17.85M
Credit Impairment Loss
-171.10%-6.59M
-135.40%-3.95M
-4.68%-4.98M
256.85%11.46M
1,308.75%9.27M
605.90%11.14M
-298.51%-4.76M
13.10%-7.31M
107.75%657.82K
118.47%1.58M
Asset Impairment Loss
1.70%-123.73K
-33.17%-92.19K
0.00%-34.61K
-232.80%-736.97K
33.45%-125.87K
45.10%-69.22K
45.10%-34.61K
-152.29%-221.44K
---189.13K
---126.09K
Other net revenue
325.25%91.93M
-91.93%1.72M
-76.25%569.47K
49.19%39.43M
26.54%21.62M
25.79%21.3M
-55.11%2.4M
547.51%26.43M
493.91%17.08M
540.19%16.93M
Fair value change income
----
----
--2.19M
--4.56M
----
----
----
----
----
----
Invest income
1,178.66%92.11M
-70.23%2.14M
-79.11%1.25M
-6.22%13.87M
245.71%7.2M
245.71%7.2M
186.02%5.96M
5,494.56%14.79M
--2.08M
--2.08M
-Including: Investment income associates
----
----
----
---217.58K
----
----
----
----
----
----
Asset deal income
-2,120.19%-251.11K
-2,282.77%-271.32K
---30.53K
99.08%-5.82K
122.88%12.43K
120.83%12.43K
----
-1,038.94%-634.52K
-180.86%-54.33K
-3,067.29%-59.66K
Other revenue
28.96%6.78M
28.90%3.88M
77.11%2.17M
-48.10%10.28M
-63.93%5.26M
-77.62%3.01M
32.60%1.23M
61.72%19.81M
29.17%14.59M
20.22%13.46M
Operating profit
-48.98%48.06M
-81.64%13.57M
-19.39%26.63M
-101.56%-1.01M
-16.56%94.2M
11.87%73.89M
26.06%33.04M
-34.59%64.85M
2.41%112.89M
-10.47%66.05M
Add:Non operating Income
5,654.69%3.08M
5,502.90%2.8M
-68.17%35.8K
25.83%518.79K
-88.17%53.56K
-85.40%49.96K
-59.10%112.46K
-59.96%412.29K
-53.84%452.6K
-32.38%342.33K
Less:Non operating expense
41.73%7.32M
-53.48%269.46K
-38.69%318.76K
150.33%5.29M
1,022.19%5.16M
95.41%579.28K
184.92%519.93K
1,371.00%2.11M
580.66%459.96K
916.37%296.44K
Total profit
-50.80%43.83M
-78.06%16.1M
-19.25%26.35M
-109.16%-5.79M
-21.08%89.09M
11.00%73.36M
24.07%32.63M
-36.87%63.15M
1.56%112.89M
-10.99%66.1M
Less:Income tax cost
-113.05%-2.38M
-98.50%117.51K
-57.48%1.96M
-97.08%398.59K
-0.15%18.22M
-8.59%7.84M
45.41%4.61M
292.64%13.67M
-0.78%18.24M
-19.87%8.57M
Net profit
-34.81%46.21M
-75.61%15.98M
-12.95%24.39M
SL-6.18M
-25.12%70.87M
13.92%65.53M
21.14%28.02M
-48.75%49.48M
2.02%94.64M
-9.49%57.52M
Net profit from continuing operation
-34.81%46.21M
-75.61%15.98M
-12.95%24.39M
-112.50%-6.18M
-25.12%70.87M
13.92%65.53M
21.14%28.02M
-48.75%49.48M
2.02%94.64M
-9.49%57.52M
Less:Minority Profit
38.41%2.11M
97.62%1.79M
-88.95%54.35K
175.94%1.85M
113.73%1.52M
68.98%904.87K
135.91%491.76K
1,197.89%671.9K
1,387.39%712.44K
344.89%535.5K
Net profit of parent company owners
-36.41%44.1M
-78.04%14.19M
-11.59%24.33M
-116.47%-8.04M
-26.17%69.35M
13.40%64.62M
20.10%27.53M
-49.42%48.81M
1.31%93.93M
-10.64%56.99M
Earning per share
Basic earning per share
-35.42%0.31
-77.78%0.1
-10.53%0.17
-117.65%-0.06
-26.01%0.48
14.33%0.45
-33.31%0.19
-49.25%0.34
-43.72%0.6487
-50.37%0.3936
Diluted earning per share
-35.42%0.31
-77.78%0.1
-10.53%0.17
-117.65%-0.06
-26.01%0.48
14.33%0.45
-33.31%0.19
-49.25%0.34
-43.72%0.6487
-50.37%0.3936
Other composite income
Total composite income
-34.81%46.21M
-75.61%15.98M
-12.95%24.39M
-112.50%-6.18M
-25.12%70.87M
13.92%65.53M
21.14%28.02M
-48.75%49.48M
2.02%94.64M
-9.49%57.52M
Total composite income of parent company owners
-36.41%44.1M
-78.04%14.19M
-11.59%24.33M
-116.47%-8.04M
-26.17%69.35M
13.40%64.62M
20.10%27.53M
-49.42%48.81M
1.31%93.93M
-10.64%56.99M
Total composite income of minority owners
38.41%2.11M
97.62%1.79M
-88.95%54.35K
175.94%1.85M
113.73%1.52M
68.98%904.87K
135.91%491.76K
1,197.89%671.9K
1,387.39%712.44K
344.89%535.5K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Reservations with explanatory notes
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -14.16%370.85M-6.15%296.99M2.15%199.95M-2.41%519.62M-8.93%432M7.04%316.44M6.50%195.74M-15.88%532.44M-5.40%474.35M-10.91%295.62M
Operating revenue -14.16%370.85M-6.15%296.99M2.15%199.95M-2.41%519.62M-8.93%432M7.04%316.44M6.50%195.74M-15.88%532.44M-5.40%474.35M-10.91%295.62M
Other operating revenue ----9.42%2.46M------5.07M----12.56%2.25M------------412.42%2M
Total operating cost 15.38%414.72M8.07%285.14M5.33%173.89M13.37%560.07M-5.05%359.42M7.03%263.85M1.34%165.1M-8.16%494.02M-3.94%378.54M-5.44%246.51M
Operating cost 7.90%195.11M2.29%143.89M-3.83%102.13M17.66%257.76M4.36%180.82M21.95%140.67M20.12%106.2M7.19%219.08M29.03%173.26M21.38%115.35M
Operating tax surcharges 599.98%9.05M719.62%5.58M2,717.77%4.72M47.68%2.81M22.67%1.29M-30.08%680.79K-79.22%167.57K-60.27%1.91M-67.27%1.05M-51.49%973.65K
Operating expense 32.10%163.24M26.26%105.65M30.78%52.34M7.85%208.19M-13.44%123.57M-10.95%83.68M-29.87%40.02M-28.50%193.03M-37.08%142.75M-35.33%93.97M
Administration expense 15.76%33.17M16.08%21.78M25.20%10.77M9.60%40.94M3.38%28.65M6.10%18.77M-1.88%8.61M50.93%37.36M55.69%27.72M51.42%17.69M
Financial expense -62.31%1.97M-53.62%1.65M-24.60%956.97K127.40%7.56M-8.11%5.22M423.19%3.57M2,018.35%1.27M209.69%3.33M253.39%5.69M126.32%682.06K
-Interest expense (Financial expense) -31.32%4.2M-21.14%3.18M-6.59%1.24M74.69%9.45M-14.31%6.12M293.39%4.04M199.35%1.33M150.52%5.41M9,754.63%7.14M1,316.61%1.03M
-Interest Income (Financial expense) -65.34%-2.31M-65.70%-1.58M-43.98%-616.54K11.97%-1.98M11.73%-1.4M19.68%-951.67K19.84%-428.22K57.46%-2.25M62.71%-1.59M59.30%-1.18M
Research and development -38.69%12.18M-60.08%6.58M-66.40%2.97M8.84%42.8M-29.22%19.87M-7.66%16.48M13.23%8.84M6.23%39.32M80.05%28.07M92.54%17.85M
Credit Impairment Loss -171.10%-6.59M-135.40%-3.95M-4.68%-4.98M256.85%11.46M1,308.75%9.27M605.90%11.14M-298.51%-4.76M13.10%-7.31M107.75%657.82K118.47%1.58M
Asset Impairment Loss 1.70%-123.73K-33.17%-92.19K0.00%-34.61K-232.80%-736.97K33.45%-125.87K45.10%-69.22K45.10%-34.61K-152.29%-221.44K---189.13K---126.09K
Other net revenue 325.25%91.93M-91.93%1.72M-76.25%569.47K49.19%39.43M26.54%21.62M25.79%21.3M-55.11%2.4M547.51%26.43M493.91%17.08M540.19%16.93M
Fair value change income ----------2.19M--4.56M------------------------
Invest income 1,178.66%92.11M-70.23%2.14M-79.11%1.25M-6.22%13.87M245.71%7.2M245.71%7.2M186.02%5.96M5,494.56%14.79M--2.08M--2.08M
-Including: Investment income associates ---------------217.58K------------------------
Asset deal income -2,120.19%-251.11K-2,282.77%-271.32K---30.53K99.08%-5.82K122.88%12.43K120.83%12.43K-----1,038.94%-634.52K-180.86%-54.33K-3,067.29%-59.66K
Other revenue 28.96%6.78M28.90%3.88M77.11%2.17M-48.10%10.28M-63.93%5.26M-77.62%3.01M32.60%1.23M61.72%19.81M29.17%14.59M20.22%13.46M
Operating profit -48.98%48.06M-81.64%13.57M-19.39%26.63M-101.56%-1.01M-16.56%94.2M11.87%73.89M26.06%33.04M-34.59%64.85M2.41%112.89M-10.47%66.05M
Add:Non operating Income 5,654.69%3.08M5,502.90%2.8M-68.17%35.8K25.83%518.79K-88.17%53.56K-85.40%49.96K-59.10%112.46K-59.96%412.29K-53.84%452.6K-32.38%342.33K
Less:Non operating expense 41.73%7.32M-53.48%269.46K-38.69%318.76K150.33%5.29M1,022.19%5.16M95.41%579.28K184.92%519.93K1,371.00%2.11M580.66%459.96K916.37%296.44K
Total profit -50.80%43.83M-78.06%16.1M-19.25%26.35M-109.16%-5.79M-21.08%89.09M11.00%73.36M24.07%32.63M-36.87%63.15M1.56%112.89M-10.99%66.1M
Less:Income tax cost -113.05%-2.38M-98.50%117.51K-57.48%1.96M-97.08%398.59K-0.15%18.22M-8.59%7.84M45.41%4.61M292.64%13.67M-0.78%18.24M-19.87%8.57M
Net profit -34.81%46.21M-75.61%15.98M-12.95%24.39MSL-6.18M-25.12%70.87M13.92%65.53M21.14%28.02M-48.75%49.48M2.02%94.64M-9.49%57.52M
Net profit from continuing operation -34.81%46.21M-75.61%15.98M-12.95%24.39M-112.50%-6.18M-25.12%70.87M13.92%65.53M21.14%28.02M-48.75%49.48M2.02%94.64M-9.49%57.52M
Less:Minority Profit 38.41%2.11M97.62%1.79M-88.95%54.35K175.94%1.85M113.73%1.52M68.98%904.87K135.91%491.76K1,197.89%671.9K1,387.39%712.44K344.89%535.5K
Net profit of parent company owners -36.41%44.1M-78.04%14.19M-11.59%24.33M-116.47%-8.04M-26.17%69.35M13.40%64.62M20.10%27.53M-49.42%48.81M1.31%93.93M-10.64%56.99M
Earning per share
Basic earning per share -35.42%0.31-77.78%0.1-10.53%0.17-117.65%-0.06-26.01%0.4814.33%0.45-33.31%0.19-49.25%0.34-43.72%0.6487-50.37%0.3936
Diluted earning per share -35.42%0.31-77.78%0.1-10.53%0.17-117.65%-0.06-26.01%0.4814.33%0.45-33.31%0.19-49.25%0.34-43.72%0.6487-50.37%0.3936
Other composite income
Total composite income -34.81%46.21M-75.61%15.98M-12.95%24.39M-112.50%-6.18M-25.12%70.87M13.92%65.53M21.14%28.02M-48.75%49.48M2.02%94.64M-9.49%57.52M
Total composite income of parent company owners -36.41%44.1M-78.04%14.19M-11.59%24.33M-116.47%-8.04M-26.17%69.35M13.40%64.62M20.10%27.53M-49.42%48.81M1.31%93.93M-10.64%56.99M
Total composite income of minority owners 38.41%2.11M97.62%1.79M-88.95%54.35K175.94%1.85M113.73%1.52M68.98%904.87K135.91%491.76K1,197.89%671.9K1,387.39%712.44K344.89%535.5K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Reservations with explanatory notes------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data